In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, RAPT Therapeutics Inc (NASDAQ: RAPT) closed at $2.06 down -5.30% from its previous closing price of $2.17. In other words, the price has decreased by -$5.30 from its previous closing price. On the day, 0.34 million shares were traded. RAPT stock price reached its highest trading level at $2.24 during the session, while it also had its lowest trading level at $2.015.
Ratios:
For a deeper understanding of RAPT Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.14 and its Current Ratio is at 8.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Barclays Downgraded its Overweight to Equal Weight on May 10, 2024, whereas the target price for the stock was revised from $13 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.
HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share. On Nov 28 ’23, another insider, HO WILLIAM, who serves as the Chief Medical Officer of the company, sold 1,500 shares for $13.72 each. As a result, the insider received 20,580 and left with 17,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 71726696 and an Enterprise Value of -37384356.
Stock Price History:
Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is -28.25%, while the 200-Day Moving Average is calculated to be -80.66%.
Shares Statistics:
For the past three months, RAPT has traded an average of 396.60K shares per day and 257790 over the past ten days. A total of 34.40M shares are outstanding, with a floating share count of 31.00M. Insiders hold about 11.19% of the company’s shares, while institutions hold 82.21% stake in the company. Shares short for RAPT as of 1723680000 were 3465198 with a Short Ratio of 8.74, compared to 1721001600 on 3625957. Therefore, it implies a Short% of Shares Outstanding of 3465198 and a Short% of Float of 13.340001.
